According to the US National Heart, Lung and Blood Institute of Statistics, the United States has nearly 500 million people suffer from heart failure disease, and 400,000 new cases each year. Without taking a heart transplant, about 25,000 to 100,000 per year suffer from heart failure, Paul died of heart disease. Only from 2000 to 2500 cases because of the number of human donor heart is extremely limited, and therefore the actual heart transplant each year, far failed to meet patient demand, resulting in many patients with disease progression or death.

Titanium has excellent biocompatibility, the body can withstand harsh physiologic environments (human PH value of 7.4) and therefore have long been used in human hip and knee joints, and transplantation. Practice has proved that the body of the titanium no rejection, no clotting phenomenon.

Faced with the needs of the medical profession and in accordance with the characteristics of titanium in recent years, especially in recent years, many research institutes professors are committed titanium artificial heart research and development work, this can save a lot of heart patients all of life, but also bring considerable economic benefits.

In short, no matter what kind of products, the use of titanium is inevitable. If the FDA through the discussion will be able to approve a titanium artificial heart as a long-term or permanent implants implanted in the human body, not only for patients who can not get planted allogeneic cardiac rehabilitation, but also bring in huge profits.